Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral metronidazole vs vaginal probiotics for bacterial vaginosis
IRCT20191104045328N10Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metronidazole in bacterial vaginosis (BV) (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Change in vaginal microbial flora and Treatment failure rate. Started May 2022; status: completed.
02
Drugs
metronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on IRCT20191104045328N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191104045328N10.